The Division of Gastroenterology and Hepatology considers educational activities at all levels a high priority. The faculty members in our division are known for their welcoming, engaging approach; they are dedicated to mentoring and training students, residents and fellows in both clinical care and research. The division generally accepts two fellows each year for the three-year fellowship program, attracting a consistently growing number of outstanding applicants from a large national pool. An important part of our mission is graduate medical education, and we train and supervise both internal medicine residents and fellows. GI subspecialty residents are provided with a broad range of clinical exposure, as well as ample research opportunities.
Our state-of-the-art endoscopy suite offers all of the technologies available for advanced therapeutic endoscopy, covering all facets of gastroenterology and liver disease. Because our GI faculty members have a broad scope of expertise, fellows receive mentoring in a wide range of interests. The GI Fellowship Program was reviewed by the ACGME in 2007 and received the full five year accreditation.
For medical students, our faculty lecture and serve as tutors for the Problem Based Learning modules. Drs. Mark Pochapin and Brian Bosworth coordinate the two-week course on gastroenterology and hepatology during the Basis of Disease course, and fourth year medical students have assisted in writing and teaching small group patient case discussions. The faculty also supervises medical students during their third-year internal medicine clerkships.
Fourth year medical students have the opportunity to participate in a variety of clinical electives: as an integral member of the general GI consult service, rotating through the Roberts Center for Inflammatory Bowel Disease, participating in the Hepatology and Liver Transplant service, and serving on the Pancreaticobiliary service. They also have the opportunity to spend more focused time pursuing basic science research at the Center for Hepatitis C (eight-week blocks), or translational research in gastrointestinal inflammation and cancer (a two-year commitment).